Annual Total Liabilities
$34.39 B
-$3.15 B-8.38%
31 December 2023
Summary:
Abbott Laboratories annual total liabilities is currently $34.39 billion, with the most recent change of -$3.15 billion (-8.38%) on 31 December 2023. During the last 3 years, it has fallen by -$5.16 billion (-13.04%). ABT annual total liabilities is now -23.84% below its all-time high of $45.15 billion, reached on 31 December 2017.ABT Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$34.33 B
+$871.00 M+2.60%
30 September 2024
Summary:
Abbott Laboratories quarterly total liabilities is currently $34.33 billion, with the most recent change of +$871.00 million (+2.60%) on 30 September 2024. Over the past year, it has dropped by -$68.00 million (-0.20%). ABT quarterly total liabilities is now -23.97% below its all-time high of $45.15 billion, reached on 31 December 2017.ABT Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABT Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -8.4% | -0.2% |
| 3 y3 years | -13.0% | -12.3% |
| 5 y5 years | -5.7% | -6.0% |
ABT Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -13.0% | at low | -12.4% | +2.7% |
| 5 y | 5 years | -13.0% | at low | -13.2% | +2.7% |
| alltime | all time | -23.8% | +2090.0% | -24.0% | +2086.2% |
Abbott Laboratories Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $34.33 B(+2.6%) |
| June 2024 | - | $33.46 B(+0.1%) |
| Mar 2024 | - | $33.42 B(-2.8%) |
| Dec 2023 | $34.39 B(-8.4%) | $34.39 B(-0.0%) |
| Sept 2023 | - | $34.40 B(-4.3%) |
| June 2023 | - | $35.95 B(-1.7%) |
| Mar 2023 | - | $36.56 B(-2.6%) |
| Dec 2022 | $37.53 B(-4.2%) | $37.53 B(+1.7%) |
| Sept 2022 | - | $36.92 B(-1.5%) |
| June 2022 | - | $37.49 B(-2.3%) |
| Mar 2022 | - | $38.38 B(-2.0%) |
| Dec 2021 | $39.17 B(-0.9%) | $39.17 B(+0.0%) |
| Sept 2021 | - | $39.16 B(-0.2%) |
| June 2021 | - | $39.24 B(+0.6%) |
| Mar 2021 | - | $39.00 B(-1.4%) |
| Dec 2020 | $39.55 B(+8.1%) | $39.55 B(+5.6%) |
| Sept 2020 | - | $37.45 B(-1.4%) |
| June 2020 | - | $37.98 B(+4.5%) |
| Mar 2020 | - | $36.35 B(-0.6%) |
| Dec 2019 | $36.59 B(+0.4%) | $36.59 B(+0.2%) |
| Sept 2019 | - | $36.52 B(-0.0%) |
| June 2019 | - | $36.53 B(+0.1%) |
| Mar 2019 | - | $36.48 B(+0.1%) |
| Dec 2018 | $36.45 B(-19.3%) | $36.45 B(-10.5%) |
| Sept 2018 | - | $40.74 B(+8.2%) |
| June 2018 | - | $37.64 B(-4.2%) |
| Mar 2018 | - | $39.31 B(-12.9%) |
| Dec 2017 | $45.15 B(+41.3%) | $45.15 B(+12.8%) |
| Sept 2017 | - | $40.03 B(+1.7%) |
| June 2017 | - | $39.36 B(+0.1%) |
| Mar 2017 | - | $39.34 B(+23.1%) |
| Dec 2016 | $31.95 B(+60.4%) | $31.95 B(+71.8%) |
| Sept 2016 | - | $18.60 B(-2.3%) |
| June 2016 | - | $19.04 B(+1.3%) |
| Mar 2016 | - | $18.80 B(-5.7%) |
| Dec 2015 | $19.92 B(+1.8%) | $19.92 B(-2.9%) |
| Sept 2015 | - | $20.51 B(-2.3%) |
| June 2015 | - | $21.00 B(-0.5%) |
| Mar 2015 | - | $21.11 B(+7.9%) |
| Dec 2014 | $19.57 B(+10.6%) | $19.57 B(+0.2%) |
| Sept 2014 | - | $19.52 B(+9.8%) |
| June 2014 | - | $17.77 B(-2.2%) |
| Mar 2014 | - | $18.17 B(+2.8%) |
| Dec 2013 | $17.69 B(-56.2%) | $17.69 B(-13.1%) |
| Sept 2013 | - | $20.34 B(-0.6%) |
| June 2013 | - | $20.48 B(+2.4%) |
| Mar 2013 | - | $20.00 B(-50.5%) |
| Dec 2012 | $40.42 B(+13.1%) | $40.42 B(+11.8%) |
| Sept 2012 | - | $36.15 B(-3.0%) |
| June 2012 | - | $37.29 B(+1.1%) |
| Mar 2012 | - | $36.87 B(+3.1%) |
| Dec 2011 | $35.75 B(-5.4%) | $35.75 B(+2.3%) |
| Sept 2011 | - | $34.94 B(-1.7%) |
| June 2011 | - | $35.53 B(-3.8%) |
| Mar 2011 | - | $36.93 B(-2.3%) |
| Dec 2010 | $37.81 B(+28.1%) | $37.81 B(+5.3%) |
| Sept 2010 | - | $35.89 B(+7.5%) |
| June 2010 | - | $33.39 B(+3.2%) |
| Mar 2010 | - | $32.35 B(+9.6%) |
| Dec 2009 | $29.52 B(+18.5%) | $29.52 B(+3.7%) |
| Sept 2009 | - | $28.47 B(+2.8%) |
| June 2009 | - | $27.71 B(+0.9%) |
| Mar 2009 | - | $27.45 B(+10.3%) |
| Dec 2008 | $24.90 B(+13.5%) | $24.90 B(+11.1%) |
| Sept 2008 | - | $22.41 B(-10.8%) |
| June 2008 | - | $25.11 B(+8.3%) |
| Mar 2008 | - | $23.20 B(+5.8%) |
| Dec 2007 | $21.94 B(-0.9%) | $21.94 B(-0.4%) |
| Sept 2007 | - | $22.01 B(+0.9%) |
| June 2007 | - | $21.82 B(-0.7%) |
| Mar 2007 | - | $21.97 B(-0.7%) |
| Dec 2006 | $22.12 B | $22.12 B(+25.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2006 | - | $17.67 B(-6.4%) |
| June 2006 | - | $18.88 B(+34.0%) |
| Mar 2006 | - | $14.09 B(-4.3%) |
| Dec 2005 | $14.73 B(+2.0%) | $14.73 B(+1.1%) |
| Sept 2005 | - | $14.57 B(+8.4%) |
| June 2005 | - | $13.44 B(-8.5%) |
| Mar 2005 | - | $14.68 B(+1.6%) |
| Dec 2004 | $14.44 B(+11.4%) | $14.44 B(-1.1%) |
| Sept 2004 | - | $14.61 B(-1.7%) |
| June 2004 | - | $14.86 B(+2.2%) |
| Mar 2004 | - | $14.54 B(+12.1%) |
| Dec 2003 | $12.97 B(-4.6%) | $12.97 B(-9.3%) |
| Sept 2003 | - | $14.29 B(+2.1%) |
| June 2003 | - | $14.00 B(+3.6%) |
| Mar 2003 | - | $13.51 B(-0.6%) |
| Dec 2002 | $13.59 B(-4.5%) | $13.59 B(+3.7%) |
| Sept 2002 | - | $13.11 B(-0.4%) |
| June 2002 | - | $13.16 B(-1.2%) |
| Mar 2002 | - | $13.32 B(-6.4%) |
| Dec 2001 | $14.24 B(+112.1%) | $14.24 B(+1.3%) |
| Sept 2001 | - | $14.05 B(+3.6%) |
| June 2001 | - | $13.56 B(-2.3%) |
| Mar 2001 | - | $13.88 B(+106.8%) |
| Dec 2000 | $6.71 B(-4.7%) | $6.71 B(+0.7%) |
| Sept 2000 | - | $6.67 B(-1.7%) |
| June 2000 | - | $6.78 B(-4.3%) |
| Mar 2000 | - | $7.09 B(+0.6%) |
| Dec 1999 | $7.04 B(-6.2%) | $7.04 B(+2.0%) |
| Sept 1999 | - | $6.90 B(+3.0%) |
| June 1999 | - | $6.71 B(-7.6%) |
| Mar 1999 | - | $7.25 B(-3.4%) |
| Dec 1998 | $7.51 B(+6.3%) | $7.51 B(+3.8%) |
| Sept 1998 | - | $7.23 B(-2.0%) |
| June 1998 | - | $7.37 B(+5.8%) |
| Mar 1998 | - | $6.97 B(-1.3%) |
| Dec 1997 | $7.06 B(+12.0%) | $7.06 B(+4.9%) |
| Sept 1997 | - | $6.73 B(+3.7%) |
| June 1997 | - | $6.50 B(+2.4%) |
| Mar 1997 | - | $6.34 B(+0.6%) |
| Dec 1996 | $6.31 B(+25.7%) | $6.31 B(+5.9%) |
| Sept 1996 | - | $5.96 B(+0.7%) |
| June 1996 | - | $5.91 B(+24.6%) |
| Mar 1996 | - | $4.75 B(-5.4%) |
| Dec 1995 | $5.02 B(+12.1%) | $5.02 B(+4.6%) |
| Sept 1995 | - | $4.79 B(+1.0%) |
| June 1995 | - | $4.75 B(+2.7%) |
| Mar 1995 | - | $4.62 B(+3.3%) |
| Dec 1994 | $4.47 B(+11.5%) | $4.47 B(+1.7%) |
| Sept 1994 | - | $4.40 B(+4.0%) |
| June 1994 | - | $4.23 B(+5.8%) |
| Mar 1994 | - | $4.00 B(-0.4%) |
| Dec 1993 | $4.01 B(+11.7%) | $4.01 B(+1.9%) |
| Sept 1993 | - | $3.94 B(+3.3%) |
| June 1993 | - | $3.81 B(+3.1%) |
| Mar 1993 | - | $3.70 B(+2.9%) |
| Dec 1992 | $3.59 B(+17.7%) | $3.59 B(+1.6%) |
| Sept 1992 | - | $3.54 B(+12.0%) |
| June 1992 | - | $3.16 B(+1.7%) |
| Mar 1992 | - | $3.11 B(+1.8%) |
| Dec 1991 | $3.05 B(+11.8%) | $3.05 B(+6.8%) |
| Sept 1991 | - | $2.86 B(-0.2%) |
| June 1991 | - | $2.86 B(+0.9%) |
| Mar 1991 | - | $2.84 B(+3.9%) |
| Dec 1990 | $2.73 B(+28.4%) | $2.73 B(-8.5%) |
| Sept 1990 | - | $2.98 B(+11.6%) |
| June 1990 | - | $2.67 B(+10.1%) |
| Mar 1990 | - | $2.43 B(+14.2%) |
| Dec 1989 | $2.13 B(-10.0%) | $2.13 B(-10.0%) |
| Dec 1988 | $2.36 B(+3.0%) | $2.36 B(+3.0%) |
| Dec 1987 | $2.29 B(+9.8%) | $2.29 B(+9.8%) |
| Dec 1986 | $2.09 B(+30.6%) | $2.09 B(+30.6%) |
| Dec 1985 | $1.60 B(+1.8%) | $1.60 B(+1.8%) |
| Dec 1984 | $1.57 B | $1.57 B |
FAQ
- What is Abbott Laboratories annual total liabilities?
- What is the all time high annual total liabilities for Abbott Laboratories?
- What is Abbott Laboratories annual total liabilities year-on-year change?
- What is Abbott Laboratories quarterly total liabilities?
- What is the all time high quarterly total liabilities for Abbott Laboratories?
- What is Abbott Laboratories quarterly total liabilities year-on-year change?
What is Abbott Laboratories annual total liabilities?
The current annual total liabilities of ABT is $34.39 B
What is the all time high annual total liabilities for Abbott Laboratories?
Abbott Laboratories all-time high annual total liabilities is $45.15 B
What is Abbott Laboratories annual total liabilities year-on-year change?
Over the past year, ABT annual total liabilities has changed by -$3.15 B (-8.38%)
What is Abbott Laboratories quarterly total liabilities?
The current quarterly total liabilities of ABT is $34.33 B
What is the all time high quarterly total liabilities for Abbott Laboratories?
Abbott Laboratories all-time high quarterly total liabilities is $45.15 B
What is Abbott Laboratories quarterly total liabilities year-on-year change?
Over the past year, ABT quarterly total liabilities has changed by -$68.00 M (-0.20%)